Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer
- PMID: 17252589
- DOI: 10.1002/hed.20544
Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer
Abstract
Background: The CD44 family of receptors includes multiple variant isoforms, some of which have been linked to tumor progression. The objective of this study was to investigate whether CD44 v3-containing isoforms are involved in head and neck squamous cell carcinoma (HNSCC) tumor progression.
Methods: Laboratory investigation utilizing HNSCC cell lines and clinical tissue specimens was performed.
Results: Investigation of 13 HNSCC cell lines revealed a diversity of CD44 isoform profiles, including expression of CD44 v3-containing isoforms. Two cell lines, HOC313 and MDA1483, were selected for further study based on their CD44 v3 expression profile. The HOC313 cell line, which highly expresses CD44 v3-containing isoforms, demonstrated hyaluronan-mediated CD44-dependent promotion of tumor cell growth and migration. Conditioned media from the HOC313 cell line also exhibited high matrix metalloproteinase expression on gelatin zymography. Immunohistochemical analysis of a series of metastatic HNSCC lymph nodes revealed CD44 overexpression as well as staining for CD44 v3-containing isoforms.
Conclusion: CD44 v3-containing isoforms are associated with HNSCC growth, migration, and matrix metalloproteinase activity and can be identified in lymph node metastasis.
(c) 2007 Wiley Periodicals, Inc. Head Neck, 2007.
Similar articles
-
CD44 variant isoforms in head and neck squamous cell carcinoma progression.Laryngoscope. 2009 Aug;119(8):1518-30. doi: 10.1002/lary.20506. Laryngoscope. 2009. PMID: 19507218 Free PMC article.
-
Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.Arch Otolaryngol Head Neck Surg. 2006 Jul;132(7):771-8. doi: 10.1001/archotol.132.7.771. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16847188
-
Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.In Vivo. 2008 Jan-Feb;22(1):89-92. In Vivo. 2008. PMID: 18396788
-
Molecular markers of metastasis in squamous carcinomas.J Pathol. 2001 Jul;194(3):289-93. doi: 10.1002/1096-9896(200107)194:3<289::AID-PATH912>3.0.CO;2-L. J Pathol. 2001. PMID: 11439359 Review.
-
Role of metalloproteins in the clinical management of head and neck squamous cell carcinoma.Head Neck. 2007 Dec;29(12):1144-55. doi: 10.1002/hed.20655. Head Neck. 2007. PMID: 17657798 Review.
Cited by
-
The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.Int J Mol Sci. 2020 May 26;21(11):3739. doi: 10.3390/ijms21113739. Int J Mol Sci. 2020. PMID: 32466374 Free PMC article.
-
Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis.Curr Mol Med. 2011 Aug;11(6):503-11. doi: 10.2174/156652411796268740. Curr Mol Med. 2011. PMID: 21663587 Free PMC article.
-
CD44 mediates the catch-bond activated rolling of HEPG2Iso epithelial cancer cells on hyaluronan.Cell Adh Migr. 2017 Sep 3;11(5-6):476-487. doi: 10.1080/19336918.2016.1260809. Epub 2017 Feb 1. Cell Adh Migr. 2017. PMID: 27874296 Free PMC article.
-
CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.Oncoimmunology. 2020 Apr 7;9(1):1747732. doi: 10.1080/2162402X.2020.1747732. eCollection 2020. Oncoimmunology. 2020. PMID: 32313730 Free PMC article.
-
Molecular signaling in cancer stem cells of tongue squamous cell carcinoma: Therapeutic implications and challenges.World J Stem Cells. 2023 May 26;15(5):438-452. doi: 10.4252/wjsc.v15.i5.438. World J Stem Cells. 2023. PMID: 37342225 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous